Not Yet RecruitingNot Applicable

AI-Assisted Real-Time Endoscopic Characterization of Diminutive Colorectal Polyps in Non-Academic Hospitals

China363 participantsStarted 2026-02-15

Plain-language summary

To validate the feasibility of promoting colorectal diminutive polyp "predict, resect, and discard" and "diagnose and leave" strategies for non-experts in general hospitals through CADx system.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Agree to participate in this prospective randomized controlled study;
✓. Age ≥18 years for colonoscopy;
✓. At least one colorectal diminutive polyp (size \<=5mm) found during examination;

Exclusion criteria

✕. Already participating in other clinical trials, having signed informed consent and being in the follow-up period of other clinical trials;
✕. Already participating in drug clinical trials and being in the washout period of experimental or control drugs;
✕. History of drug or alcohol abuse or psychological disorders in the past five years;
✕. Pregnant or lactating patients;
✕. Known polyposis syndromes;
✕. Patients with gastrointestinal bleeding;
✕. Previous history of inflammatory bowel disease, colorectal cancer, or colorectal surgery;
✕. Patients with contraindications to tissue biopsy;

What they're measuring

Agreement between optical- and histology-based post-polypectomy surveillance intervals according to United States Multi-Society Task Force (USMSTF) guidelines

Timeframe: 14 days

Negative Predictive Value for Diagnosing Neoplastic Lesions in Rectosigmoid Diminutive Polyps under High Confidence

Timeframe: 14 days

Trial details

NCT IDNCT07362524

SponsorShanghai Jiao Tong University School of Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-11-15

Contact for this trial

Xiaobo Li, PhD

86+13901631056 lxb_1969@163.com

View on ClinicalTrials.gov More Colorectal Polyps trials

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Agree to participate in this prospective randomized controlled study;
✓. Age ≥18 years for colonoscopy;
✓. At least one colorectal diminutive polyp (size \<=5mm) found during examination;

Exclusion criteria

✕. Already participating in other clinical trials, having signed informed consent and being in the follow-up period of other clinical trials;
✕. Already participating in drug clinical trials and being in the washout period of experimental or control drugs;
✕. History of drug or alcohol abuse or psychological disorders in the past five years;
✕. Pregnant or lactating patients;
✕. Known polyposis syndromes;
✕. Patients with gastrointestinal bleeding;
✕. Previous history of inflammatory bowel disease, colorectal cancer, or colorectal surgery;
✕. Patients with contraindications to tissue biopsy;

What they're measuring

Agreement between optical- and histology-based post-polypectomy surveillance intervals according to United States Multi-Society Task Force (USMSTF) guidelines

Timeframe: 14 days

Negative Predictive Value for Diagnosing Neoplastic Lesions in Rectosigmoid Diminutive Polyps under High Confidence

Timeframe: 14 days